Curon BioPharma engages in biopharmaceutical development, focusing on creating new treatment options. Self-described capabilities include innovative scientific approaches.

Curon BioPharma

Asia Startups Founded in 2018

Biotechnology Companies (Top 10K)

Private China Companies (Top 10K)

Biotechnology Early Stage Companies With Fewer Than 1000 Employees

Curon Biopharma is a developer of drugs intended designed for immuno-oncology therapies. The company's drugs consist of multiple class-leading cancer immunotherapeutic agents in the world that could address the shortcomings of current cancer treatment paradigm, enabling a physician to provide advanced cancer immunotherapies to their patients.

Series A - Curon Biopharma

Shanghai

China

Asia

Curon Biopharma

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 29, 2024 12:44 PM	703c6e1f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 29, 2024 12:44 PM	9b45b4ff
crunchbase trigger	general	Oct 30, 2024 1:02 PM	64dc6ae6
crunchbase profile	general	Oct 31, 2024 6:30 AM	947d53dd
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	63de333d
peers	general	Sep 29, 2024 12:44 PM	c6e3cfe7
news basic	general	Sep 29, 2024 12:44 PM	ec01f885
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

CURO

COM:CURONBIOPHARMA

Curon BioPharma